5PSQ-022 Pharmacological cardioversion in patients with recent-onset atrial fibrillation at emergency department: efficacy and safety of vernakalant

BACKGROUND: Atrial fibrillation (AF) is one of the most common clinically significant cardiac arrhythmias. The management of AF includes conversion to sinus rhythm (SR). Vernakalant is a multi-channel blocker that has effectively converted recent-onset AF and has been well tolerated in placebo-contr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hosp Pharm
Main Authors: Requejo, C Caballero, Candela, M Onteniente, Muñoz, C Gallego, Candel, M Gil, Valverde, I Salar, Sanz, E Urbieta, Salmerón, P Piñera
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2018
Assuntos:
Section 5: Patient safety and quality assurance
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535319/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.376
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados